Literature DB >> 6228354

Immunological studies of autoimmune thyroid disorders: abnormalities in the inducer T cell subset and proliferative responses to autologous and allogeneic stimulation.

C Fournier, H Chen, A Leger, J Charreire.   

Abstract

Various immunological parameters were investigated in patients with Hashimoto's thyroiditis (HT) and Graves' disease (GD). The total T cell numbers were significantly decreased in both diseases whether they were enumerated by E rosetting or by pan-T cell monoclonal antibodies (OKT3 and anti-Leu 1). This diminution was due to a loss in the inducer T cell subset (OKT4+/Leu 3a+) whereas the cytotoxic/suppressor T cells (OKT8+/Leu 2a+) were present at normal levels in both diseases. The B cells were significantly higher in GD patients than in controls but were not modified in HT patients. Monocyte percentages remained unchanged and DR+ cells were slightly increased in the two diseases. On the other hand, T lymphocyte responses to stimulation by autologous or allogeneic cells were significantly impaired in GD but not in HT whether cultures were performed in autologous plasma or AB serum. In addition, lymphocytes from normal subjects were unable to proliferate in auto- or allo-MLR in the presence of plasma from GD patients but they were reactive in the presence of HT plasma or AB serum. Taken together, these results suggest that the patients with autoimmune thyroid disorders exhibit a T cell imbalance within the OKT4+/Leu 3a+ subset. Moreover, this abnormality is correlated with the observation that autoreactive and alloreactive cells are defective in GD.

Entities:  

Mesh:

Year:  1983        PMID: 6228354      PMCID: PMC1535910     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Lymphocyte populations in peripheral blood in hyperthyroid and euthyroid subjects.

Authors:  G Lundell; J Wasserman; P O Granberg; H Blomgren
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

2.  Letter: Proportion of E rosettes normal in Graves's and Hashimoto's disease: a retraction.

Authors:  R Volpé; V V Row
Journal:  N Engl J Med       Date:  1975-07-03       Impact factor: 91.245

3.  Evidence for circulating immune complexes in thyroid disease.

Authors:  E A Calder; W J Penhale; E W Barnes; W J Irvine
Journal:  Br Med J       Date:  1974-04-06

4.  Circulating lymphocyte subpopulations in Hashimoto thyroiditis.

Authors:  S J Urbaniak; W J Penhale; W J Irvine
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

5.  Lymphocyte-dependent antibody-mediated cytotoxicity in Hashimoto thyroiditis.

Authors:  E A Calder; W J Penhale; D McLeman; E W Barnes; W J Irvine
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

6.  Studies on suppressor cell function in thyroid diseases.

Authors:  N Aoki; K M Pinnamaneni; L J DeGroot
Journal:  J Clin Endocrinol Metab       Date:  1979-05       Impact factor: 5.958

7.  Lack of T-cell immune abnormalities in peripheral blood lymphocytes in patients with Graves' disease or hypothyroidism.

Authors:  C Mulaisho; N I Abdou; R D Utiger
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

8.  T, B and K cells in autoimmune thyroid disease.

Authors:  E A Calder; W J Irvine; N M Davidson; F Wu
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

9.  Total and "activated" peripheral blood T lymphocytes in patients with thyroid disorders.

Authors:  J R Wall; B Gray; D M Greenwoood
Journal:  Acta Endocrinol (Copenh)       Date:  1977-08

10.  Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes.

Authors:  M M Kuntz; J B Innes; M E Weksler
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  5 in total

1.  Quantitative immunological differences between newly diagnosed Graves' disease patients and relapsed patients.

Authors:  U Di Mario; F P Cavatorta; R Perfetti; G Pugliese; P Pozzilli; J Sutherland; M Vitillo; D Andreani
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

2.  Thyroid stimulating immunoglobulin (TSI) synthesis by pokeweed mitogen (PWM) stimulated peripheral blood lymphocytes (PBL) from Graves' disease (GD) patients.

Authors:  B Pautard; J J Rémy; J Charreire
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

3.  The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes.

Authors:  K Van der Weerd; P M Van Hagen; B Schrijver; D J Kwekkeboom; W W De Herder; M R J Ten Broek; P T E Postema; J J M Van Dongen; F J T Staal; W A Dik
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

4.  Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.

Authors:  J Charreire; G Karsenty; P Bouchard; G Schaison
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

5.  Clinical and immunological studies on patients with Graves' disease preoperatively treated with corticosteroids and iodides.

Authors:  Y Kasuga; A Sugenoya; S Kobayashi; G Kaneko; H Masuda; M Fujimori; S Takahashi; F Iida
Journal:  Jpn J Surg       Date:  1990-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.